Dualogics - OrthoMab Bispecific Platform - Ownership and Business Overview

Life ScienceCompany

Dualogics - OrthoMab Bispecific Platform Ownership

Who owns Dualogics - OrthoMab Bispecific Platform?

Dualogics - OrthoMab Bispecific Platform is owned by AbCellera Biologics. It was acquired on August 20, 2020.

Dualogics - OrthoMab Bispecific Platform Business Overview

Where is Dualogics - OrthoMab Bispecific Platform headquartered?

Dualogics - OrthoMab Bispecific Platform is headquartered in Chapel Hill, North Carolina.

What sector is Dualogics - OrthoMab Bispecific Platform in?

Dualogics - OrthoMab Bispecific Platform is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 291 acquisitions of life science companies in 2020, including 24 acquisitions by private equity firms, and 267 by strategics.

Dualogics LLC - OrthoMab Bispecific Platform

Chapel Hill, North Carolina 27516
United States,

Dualogics LLC - OrthoMab Bispecific Platform can combine any two existing antibody sequences to create bispecifics that are 99% identical to natural human antibodies. OrthoMab antibodies are produced using standard production and purification techniques and are available in flexible formats that can be tailored to specific target biology and mechanisms of action.


 Subscribe to unlock this and 209,497
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.